ym 16151-1 has been researched along with arginine vasopressin in 1 studies
Studies (ym 16151-1) | Trials (ym 16151-1) | Recent Studies (post-2010) (ym 16151-1) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
---|---|---|---|---|---|
7 | 0 | 0 | 12,278 | 422 | 1,212 |
Protein | Taxonomy | ym 16151-1 (IC50) | arginine vasopressin (IC50) |
---|---|---|---|
Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asano, M; Shibasaki, K; Takenaka, T; Uchida, W | 1 |
1 other study(ies) available for ym 16151-1 and arginine vasopressin
Article | Year |
---|---|
Antianginal effects of YM-16151-4 in various experimental angina models.
Topics: 4-Aminopyridine; Amifampridine; Angina Pectoris; Animals; Arginine Vasopressin; Atrioventricular Node; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Dihydropyridines; Dogs; Electrocardiography; Female; Heart Conduction System; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitrophenols; Oxygen Consumption; Potassium Channels; Propranolol | 1993 |